Medscape, March 26, 2019
A snapshot of CardioTwitter shows that the Apple Heart Study dominated on Saturday, and while there was some discussion of the TAVR trials after the embargo break, the topic didn’t peak until the live presentations on Sunday as mentions of Apple waned (Symplur provided the data for #ACC19).
— Medscape
